Market Currents
St. Jude Medical (STJ -6%) could receive a warning letter from the FDA about its manufacturing...
-
Wednesday, October 17, 2012, 9:33 AM ETSt. Jude Medical (STJ -6%) could receive a warning letter from the FDA about its manufacturing facility in Sylmar, California, where it produces defibrillators and pacemakers and which the FDA is inspecting. The news, which CEO Dan Starks disclosed on an earnings call, is not a surprise given the massive insulation problems St. Jude has had with the wires for its defibrillators.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: